← Browse by Condition
Medical Condition

aggressive systemic mastocytosis asm

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT04996875 Phase 2
Recruiting

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Enrollment
140 pts
Location
United States, Austr...
Sponsor
Cogent Biosciences, Inc.
View Trial →